Many academic founders mistakenly assume that because they conceptualized a breakthrough in the lab, they automatically own the commercial rights
Signing an AI vendor agreement without legal scrutiny is one of the most consequential mistakes a startup founder can make.
Startups are rapidly integrating generative AI to scale software development and design. However, this speed introduces critical legal vulnerabilities regarding
Life sciences startups often invest significant capital into research and development long before generating stable revenue. For these early-stage companies,
Structuring your startup equity compensation correctly is often the deciding factor in whether your company survives its first five years.
The equity compensation strategy that launched your biotech company in 2024 requires careful re-evaluation in 2026. Two years ago, your
